{
    "organizations": [],
    "uuid": "cc6e4364511bfb6f16d587d5b7d3e0b3f7770e4a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-endocyte-reports-q1-loss-per-share/brief-endocyte-reports-q1-loss-per-share-0-16-idUSASC0A0Z6",
    "ord_in_thread": 0,
    "title": "BRIEF-Endocyte Reports Q1 Loss Per Share $0.16",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 9 (Reuters) - Endocyte Inc:\n* Q1 LOSS PER SHARE $0.16 * Q1 EARNINGS PER SHARE VIEW $-0.19 â€” THOMSON REUTERS I/B/E/S\n* PHASE 3 VISION TRIAL ON TRACK FOR FIRST PATIENT VISIT IN Q2 2018\n* CASH, CASH EQUIVALENTS AND INVESTMENTS WERE $173.1 MILLION AT MARCH 31, 2018\n* ANTICIPATES ITS CASH, CASH EQUIVALENTS AND INVESTMENTS BALANCE AT END OF 2018 TO EXCEED $130 MILLION\n* ENDOCYTE - SUFFICIENT CASH TO FUND ACTIVITIES THROUGH EXPECTED END OF VISION TRIAL, POTENTIAL PROOF OF CONCEPT OF ITS EC17/CAR T-CELL THERAPY Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-09T20:12:00.000+03:00",
    "crawled": "2018-05-10T17:28:10.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "endocyte",
        "inc",
        "q1",
        "loss",
        "per",
        "share",
        "q1",
        "earnings",
        "per",
        "share",
        "view",
        "thomson",
        "reuters",
        "phase",
        "vision",
        "trial",
        "track",
        "first",
        "patient",
        "visit",
        "q2",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "million",
        "march",
        "anticipates",
        "cash",
        "cash",
        "equivalent",
        "investment",
        "balance",
        "end",
        "exceed",
        "million",
        "endocyte",
        "sufficient",
        "cash",
        "fund",
        "activity",
        "expected",
        "end",
        "vision",
        "trial",
        "potential",
        "proof",
        "concept",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}